SV
Sky Ventures Group
Venture CapitalActiveA Boston-based investment group that provides funding to early-stage life science and healthcare companies.
15
Investments
2
Exits
—
AUM
13.3%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Sky Ventures Group.
Investment Thesis & Strategy
Sky Ventures Group invests in early-stage life science and healthcare companies, providing them with the capital needed to grow and scale their businesses.
Investment Activity
Deals per year over the last 5 years
1
20171
20182
20191
20205
2021Portfolio Companies
Selected investments from their portfolio of 15 companies
V
Vaxess Technologies
Biotech · Series B, 2021
C
Cellino
Biotech · Series A, 2021
E
Enara Bio
Biotech · Series A, 2021
C
C2i Genomics
Biotech · Series A, 2021
K
Korro Bio
Biotech · Series A, 2021
T
TScan Therapeutics
Biotech · Series B, 2020
V
Verve Therapeutics
Biotech · Series A, 2019
X
Xilio Therapeutics
Biotech · Series A, 2019
A
Affinivax
Biotech · Series B, 2018
P
PathAI
Healthcare · Series B, 2017
Frequently Asked Questions
Sky Ventures Group focuses on Series A, Series B, Series C+ stage investments.